Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (86)
  • 2024 (92)
  • 2023 (138)
  • 2022 (178)
  • 2021 (117)
  • 2020 (15)
  • 2019 (21)
  • 2018 (7)
  • 2017 (3)
  • 2003 (1)

Subject

  • Drug Trafficking (4016)
  • Synthetic drugs (1067)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (605)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (458)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (243)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (111)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (7)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (364)
  • Overdose (321)

Drug Name

  • Fentanyl (262)
  • Oxycodone (82)
  • Opioids (60)
  • Heroin (51)
  • Cocaine (44)
  • Synthetic Opioids (41)
  • Methamphetamine (33)
  • Hydromorphone (19)
  • Benzodiazepines (14)
  • Morphine (10)
  • Amphetamines (9)
  • Marijuana (Cannabis) (8)
  • Ketamine (5)
  • Methadone (5)
  • Steroids (3)
  • Ecstasy/MDMA (2)
  • K2/Spice (2)
  • Marijuana Concentrates (2)
  • GHB (1)
  • Psilocybin (1)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Xylazine (1)

Field Division

  • Washington, DC (99)
  • New York (85)
  • St. Louis (67)
  • Atlanta (38)
  • San Diego (37)
  • Seattle (36)
  • Miami (30)
  • El Paso (26)
  • New England (26)
  • Los Angeles (25)
  • Sede (24)
  • Dallas (22)
  • Omaha (22)
  • Chicago (21)
  • San Francisco (21)
  • Houston (18)
  • New Jersey (17)
  • Louisville (13)
  • New Orleans (10)
  • Phoenix (8)
  • Rocky Mountain (6)
  • Detroit (5)
  • Philadelphia (2)
Clear All Results
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day

Agosto 19, 2022
EL PASO – On Sunday, August 21, the Drug Enforcement Administration will recognize National Fentanyl Prevention and Awareness Day by joining the many voices dedicated to educating the public on the serious dangers of fentanyl poisoning from fake pills and other illicit drugs. DEA supports the efforts of several organizations...
Agosto 19, 2022
PRESS RELEASE

Leader of “Mike’s Candyshop” Drug Delivery Service Sentenced to 22 Years in Prison In Connection with the Overdose Death of Colin Kroll

Agosto 12, 2022
NEW YORK CITY – Ariel Tavarez, a/k/a “A,” a/k/a “Mike,” was sentenced to 264 months in prison in connection with his conspiring to distribute heroin, cocaine, fentanyl, and a fentanyl analogue, and to distributing narcotics that caused the 2018 death of Colin Kroll, the co-founder of the video hosting service...
Agosto 12, 2022
PRESS RELEASE

New Jersey Pharmacy Admits Illegal Distribution of Prescription Opioids and Kickback Scheme

Agosto 03, 2022
NEWARK, N.J. – Susan A. Gibson, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, Scott J. Lampert, Special Agent in Charge of the U.S. Department of Health and Human Services, Office of Inspector General, Office of Investigations-New Jersey Field Office, Patrick J. Hegarty, Defense Criminal Investigative...
Agosto 03, 2022
PRESS RELEASE

Man Arrested on Federal Charges of Selling Fake Pills that caused Fatal Fentanyl Overdose

Agosto 01, 2022
LOS ANGELES – A Paso Robles man has been arrested on federal charges of selling counterfeit prescription pills containing fentanyl to a 19-year-old Atascadero resident who suffered a fatal overdose from the synthetic opioid, the Justice Department announced today. Timothy Clark Wolfe, 24, was taken into custody Thursday by special...
Agosto 01, 2022
PRESS RELEASE

Justice Department Obtains Temporary Restraining Order to Prevent Tampa-Area Physician from Writing Opioid Prescriptions

Julio 29, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area physician from prescribing opioids and other controlled substances, the Department of Justice announced today. In a complaint filed on July 18, and unsealed yesterday, the United States alleges that Dr. Neelam Taneja Uppal unlawfully wrote opioid prescriptions...
Julio 29, 2022
PRESS RELEASE

Federal Court Orders Clinic to Close, Physician and Clinic Owners to Pay $600,000 for Alleged Unlawful Opioid Distribution

Julio 27, 2022
WASHINGTON – A federal court ordered a Tampa-area pain management clinic to close and directed the clinic’s owners and its former physician to collectively pay $600,000 in civil penalties pursuant to agreed resolutions in a case alleging violations of the Controlled Substances Act (CSA), the Justice Department announced today. In...
Julio 27, 2022
PRESS RELEASE

Minnesota Pharmacist Pleads Guilty to Misappropriating and Adulterating Prescription Pain Medication

Julio 20, 2022
MINNEAPOLIS – A Minneapolis woman has pleaded guilty to misappropriating and adulterating prescription morphine while working as a pharmacist. According to court documents, on October 30, 2019, Jennifer Lee Draheim, 42, a pharmacist at Coburn’s Pharmacy in Ramsey, removed a bottle of morphine sulfate from the Scheduled Drug Cabinet and...
Julio 20, 2022
PRESS RELEASE

Baltimore Fentanyl Dealer Sentenced to Over Seven Years in Federal Prison for Selling Fentanyl and Other Narcotics to Customers Across Four States

Julio 20, 2022
Baltimore, Md., – Yesterday U.S. District Judge Richard D. Bennett sentenced Devin Cunningham, age 27, of Baltimore, to 87 months in federal prison, followed by four years of supervised release, for conspiracy to distribute and possess with intent to distribute controlled substances and possession with intent to distribute controlled substances...
Julio 20, 2022
PRESS RELEASE

East Windsor Man Admits Role In Oxycodone Prescription Fraud Scheme

Julio 19, 2022
EAST WINDSOR, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, today announced that an East Windsor man has admitted his role in a scheme to acquire and distribute oxycodone obtained through fraudulent prescriptions. On July 5, 2022, JAYSON KEMP, 45, pleaded guilty before U.S. District...
Julio 19, 2022
PRESS RELEASE

Oklahoma City Hospital Pays $120,000 to Settle Civil Penalty Claims

Julio 19, 2022
OKLAHOMA CITY, OK – INTEGRIS ProHealth, Inc., and its parent, INTEGRIS Health, Inc. (collectively, “INTEGRIS”) paid $120,000 to settle civil penalty claims stemming from allegations that Integris Baptist Medical Center Pharmacy (“Integris Pharmacy”), which is owned and operated by INTEGRIS ProHealth, Inc., violated the Comprehensive Drug Abuse Prevention and Control...
Julio 19, 2022
Showing 371 - 380 of 658 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 34
  • Página 35
  • Página 36
  • Página 37
  • Current page 38
  • Página 39
  • Página 40
  • Página 41
  • Página 42
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster